Pierre Devaux

Pharmacist – CEO Theraxel-Point Forty Five

Theraxel-Point Forty Five is a Company specialized in consulting, technical assistance, regulatory audits and training around the control of the chemical risk, Microbiological, particulate and pyrogenic for non-sterile, sterile and biotechnological pharmaceutical industries as well as related industries such as cosmetic industries.

Pierre Devaux is a specialist in Part I, Annex 1 and Annex 15 of the European GMP, ICHQ9 and FDA guidelines on aseptic and validation processes and ISO22716

He has the following experience:

  • 6 years as responsible for the quality control laboratories and the management of the environmental monitoring of the ZAC of the Excelvision Fareva French site;
  • 5 years as Qualified Person/Quality Director of the ACM Pharma French laboratory, while carrying out consulting missions via the company UPS Consultants.
  • Head within the French Association A3P of the Common Interest Group on GMP Annex 15 and Cleaning Validation.
  • Speaker for ISPE Nordic and Trainer for A3P Services as well as for Key2Compliance®.
Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp
Share on email

Related courses to Pierre Devaux

New perspectives on Cross Contamination and Cleaning validation

Nov 19
- Nov 19, 2020

Decontamination Process and the new Draft of the EU GMP Annex 1

Nov 16
- Nov 16, 2020

Cleaning validation of pharmaceutical process equipment

Dec 14
- Dec 17, 2020

Biocleaning: Cleaning and decontamination of surfaces

Dec 14
- Dec 15, 2020

EU Annex 1 - Manufacture of Sterile Medicinal Products

Nov 30
- Dec 3, 2020

Contamination Control Strategy

Nov 30
- Dec 1, 2020



For your best experience are we using cookies on this website.